Wei Lou

6.7k citations
111 papers · 5.2k indexed · h-index 45

Impact in

Papers in

Wei Lou

107 papers receiving 5.1k citations

Peers

Wei Lou
Comparison fields: 5 of 130
  • Cancer Research 1.5k
  • Pulmonary and Respiratory Medicine 2.1k
  • Oncology 1.5k
  • Molecular Biology 2.7k
  • Immunology and Allergy 192
Replace Claudio Festuccia with:
Claudio Festuccia Italy
Adrie van Bokhoven United States
Allen C. Gao United States
Jeffrey E. Green United States
F. Michael Yakes United States
Wolfgang Mikulits Austria
Benjamin D. Hopkins United States
Yangfu Jiang China
Stefano Pepe Italy
Tsunehiro Oyama Japan
Wei Lou relative to Claudio Festuccia Italy Claudio Festuccia's profile →
Citations per field
00.5×
Claudio Festuccia · 1×
Citations per year

Countries citing papers authored by Wei Lou

Since Specialization
Citations

This map shows the geographic impact of Wei Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lou more than expected).

Fields of papers citing papers by Wei Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lou. The network helps show where Wei Lou may publish in the future.

Co-authors

The 25 scholars most cited alongside Wei Lou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei Lou Line = papers co-authored together Wei Lou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014295
2 2000238
3 2015196
4
Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells.
2000184
5
Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen.
1997167
6 2011160
7
CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13.
1997159
8
Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells.
2003158
9 2013156
10 2012147
11 2002120
12 2006116
13
Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
1999110
14 2013104
15 2015100
16 201697
17 202292
18 201091
19 201391
20 200988

About Wei Lou

Wei Lou is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Immunology and Allergy and Molecular Biology, having authored 111 papers that have together received 5.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (50 papers), Cytokine Signaling Pathways and Interactions (12 papers), Cancer, Lipids, and Metabolism (11 papers), Cancer-related gene regulation (10 papers), NF-κB Signaling Pathways (10 papers), Ubiquitin and proteasome pathways (10 papers), PARP inhibition in cancer therapy (9 papers) and Hormonal and reproductive studies (8 papers). The work is most often cited by research in Cancer Research (1.5k citations), Pulmonary and Respiratory Medicine (2.1k citations), Oncology (1.5k citations), Molecular Biology (2.7k citations) and Immunology and Allergy (192 citations). Wei Lou has collaborated with scholars based in United States, China and Czechia. Frequent co-authors include Allen C. Gao, Nagalakshmi Nadiminty, Christopher P. Evans, Chengfei Liu, Yezi Zhu, Soo Ok Lee, John T. Isaacs, Ramakumar Tummala, Cameron M. Armstrong and Joy C. Yang. Their work appears in journals such as The Prostate, Molecular Cancer Therapeutics, The Journal of Urology, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026